Skip to main content
. 2013 Jan 17;2(4):mmrr.002.04.a07. doi: 10.5600/mmrr.002.04.a07

Exhibit 2. Additional 6-month cost of care among Medicaid cancer patients <65 years old with select comorbid conditions compared with cancer patients without these conditions1.

Cardiac Respiratory Diabetes Mental health2 One Condition Two Conditions Three/Four Conditions
AC3 P-value AC P-value AC P-value AC P-value AC P-value AC P-value AC P-value
Including those who died during the 6-month follow-up
 Hospital stays $2,732 0.028 $4,618 0.001 $4,678 0.000 $4,979 0.000 $1,824 0.142 $7,000 <.0001 $14,596 <.0001
 Prescpt. drug $168 0.179 $345 0.016 $1,037 <.0001 $546 0.000 $373 0.003 $967 <.0001 $1,715 <.0001
 Long-term care $362 0.038 -$28 0.888 $601 0.001 $1,722 <.0001 $335 0.054 $861 <.0001 $2,066 <.0001
 Amb.care svcs. $156 0.622 $105 0.771 $1,167 0.000 $756 0.045 $646 0.040 $976 0.013 $1,787 0.001
Total $3,418 0.011 $5,040 0.001 $7,483 <.0001 $8,004 <.0001 $3,177 0.018 $9,804 <.0001 $20,165 <.0001
Excluding those who died during the 6-month follow-up (continuous follow-up for 6 months)
 Hospital stays $3,311 0.020 $6,714 <.0001 $5,112 0.000 $6,883 0.000 $2,727 0.046 $9,891 <.0001 $18,211 <.0001
 Prescpt. drug $288 0.060 $488 0.006 $1,011 <.0001 $715 <.0001 $435 0.003 $1,033 <.0001 $2,199 <.0001
 Long-term care $525 0.028 $147 0.594 $683 0.003 $2,214 <.0001 $416 0.070 $1,126 0.000 $2,933 <.0001
 Amb.care svcs. $261 0.501 $807 0.073 $909 0.015 $1,198 0.008 $1,006 0.007 $1,319 0.005 $2,396 0.000
Total $4,385 0.005 $8,155 <.0001 $7,714 <.0001 $11,009 <.0001 $4,584 0.002 $13,369 <.0001 $25,739 <.0001
1

Regression analysis controlled for differences in age, sex, race, state, stage at diagnosis and cancer site. All measures reported are per person. Medicaid cost is reported for the six month period after diagnosis in 2003 dollars.

2

Includes schizophrenic disorders, episodic mood disorders, delusional disorders, anxiety/personality disorders, and depressive disorders.

3

AC–Additional cost of chronic conditions among cancer patients; that is, increased cost of cancer care due to the presence of the comorbid condition.